Cargando…
IGF2BP1 promotes mesenchymal cell properties and migration of tumor-derived cells by enhancing the expression of LEF1 and SNAI2 (SLUG)
The oncofetal IGF2 mRNA-binding protein 1 (IGF2BP1) controls the migration and invasiveness of primary as well as tumor-derived cells in vitro. Whether the protein also modulates epithelial-mesenchymal-transition (EMT), a hallmark of tumor progression involved in tumor cell dissemination, remained e...
Autores principales: | Zirkel, Anne, Lederer, Marcell, Stöhr, Nadine, Pazaitis, Nikolaos, Hüttelmaier, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711427/ https://www.ncbi.nlm.nih.gov/pubmed/23677615 http://dx.doi.org/10.1093/nar/gkt410 |
Ejemplares similares
-
IGF2BP1: A post-transcriptional “driver” of tumor cell migration
por: Stöhr, Nadine, et al.
Publicado: (2012) -
The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancer
por: Müller, Simon, et al.
Publicado: (2020) -
IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer
por: Bley, Nadine, et al.
Publicado: (2020) -
IGF2BP1, a Conserved Regulator of RNA Turnover in Cancer
por: Glaß, Markus, et al.
Publicado: (2021) -
Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?
por: Bell, Jessica L., et al.
Publicado: (2012)